PRKAA2 and cardiomyopathy: Indeed, the gain-of-function mutations of the AMPK γ2 subunit result in severe cardiomyopathy in humans (115, 116), suggesting that the activation of some AMPK isoforms or holoenzymes can be detrimental to the heart under certain conditions.